网站首页
部门简介
招生工作
学科导师
培养工作
学位工作
就业工作
学生事务
研究生会
下载专区
研究生部 Department of Postgraduate Students 搜索
搜索
首页 > 学科导师 > 人类重大疾病生物治疗 > 博导
钱志勇 人类重大疾病生物治疗
2026-05 | 博导

  • anderson-qian@163.com

    • 肿瘤生物治疗基础与应用研究
  • 钱志勇,四川大学二级教授/博导,国家级人才主要研究方向包括纳米生物材料与纳米药物的构建及其在肿瘤治疗与组织修复中的应用基础研究。以通讯/共同通讯作者身份在Nat Commun STTTAdv  MaterActa Pharm Sinica B等本领域国际学术期刊发表高水平学术论文 100 余篇,被他引10000余次。有22项中国发明专利获得授权,三组专利技术与企业达成转让协议,已获得2项药物临床试验批件。以第一完成人身份获得2019年度高等学校科学研究院优秀成果奖(科学技术)自然科学奖一等奖。2015⁓2025连续入选Elsevier中国高被引学者榜单。

  • 担任Med-Comm-Biomaterials and Applications共同主编,担任Chinese Chemical Letters期刊执行主编,担任Signal Transduction and Targeted Therapy、Journal of Biological Engineering期刊副主编。担任中国医药生物技术协会纳米生物技术分会主任委员。

  • 1, Yun Yang, Qingya Liu, Meng Wang, Lang Li, Yan Yu, Meng Pan, Danrong Hu, Bingyang Chu, Ying Qu, Zhiyong Qian*. Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer. Signal Transduction and Targeted Therapy. 2024, 9: 158

    2, Liqun Dai, Jie Liu, Tingyu Yang, Xiaorui Yu, Yi Lu, Lili Pan, Siming Zhou, Diyun Shu, Yuanhao Liu, Wuyu Mao*Zhiyong Qian*. Lipoic acid-boronophenylalanine-derived multifunctional vesicles for cancer chemoradiotherapy. Nature Communications. 2025, 16:1329

    3, Kun Shi#, Tao Li#, Xulin Hu, Wen Chen, Yan Yu, Zhongwu Bei, Liping Yuan, Qi Tong, Jiafeng Liu, Qiang Fan, Yongjun Qian*, Zhiyong Qian.* Injectable and Sprayable Thermoresponsive Hydrogel with Fouling-resistance as an Effective Barrier to Prevent Postoperative Cardiac Adhesions. Adv Sci. 2025, 12 (23), 2500731  

    4, Kai Zhou#, Xinlong He#, Kun Shi, Danrong Hu, Chenli Yang, Mei Gao, Yiling Wang, Yue Liu, Qian Yang, Binyang Chu, Jinrong Peng, Zhiyong Qian*. A Dual Responsive Nanohydrogel System for Sustained Drug Delivery and Cartilage Penetration in Osteoarthritis Therapy. J Control Rel.  2026, 389: 114494

    5, Ziyan Feng#, Yongchao Yao#, Ziyao Wang, Xi Xiang, Liyun Wang, Xueyang Xiao, Yuanjiao Tang, Wenchuang Hu, Li Qiu*, Zhiyong Qian*. A multimodal imaging nanobubble enhancing sonodynamic therapy by cell membrane disruption for effective anti-melanoma. Biomaterials, 2026, 324: 123450

    6, Danrong Hu#, Yicong Li#, Ran Li, Meng Wang, Kai Zhou, Chengqi He, Quan Wei, Zhiyong Qian*. Recent advances in reactive oxygen species (ROS)-responsive drug delivery systems for photodynamic therapy of cancer. Acta Pharm Sinica B. 2024, 14 (12) 5106-5131

    7, Liqun Dai#, Tao Wang#, Siming Zhou, Lili Pan, Yi Lu, Tingyu Yang, Wentao Wang, Zhiyong Qian*. Boronophenylalanine-containing polydopamine nanoparticles for enhanced combined boron neutron capture therapy and photothermal therapy for melanoma treatment. Adv Funct Mater. 2024, 34 (38), 2402893  

    8, 2026.01- 2030.12, 新型细胞膜仿生纳米体系的构建及其在多发性骨髓瘤治疗中的应用基础研究,国家自然科基金重点项目(NSFC32530059),直接经费:216万元

    9,2026.01- 2030.12, 新型细胞膜仿生纳米体系的构建及其在多发性骨髓瘤治疗中的应用基础研究,国家自然科学基金重点项目(NSFC32530059),直接经费:216万元 ---- 在研

    10,2020.01-2024.12功能化载药体系的建及其在体瘤免疫合治中的用基础研家自然科基金重点项目(NSFC 31930067),直接经费:296万元

上一篇:秦廷武

下一篇:欧阳亮